(Q42911912)

11 November 2017

0 references

Improving apoptotic responses to targeted therapy (English)

1 reference

11 November 2017

1 reference

2

David E Fisher

1 reference

11 November 2017

Rizwan Haq

1

1 reference

11 November 2017

language of work or name

English

0 references

publication date

1 September 2013

1 reference

11 November 2017

1 reference

11 November 2017

4

1 reference

11 November 2017

9

1 reference

11 November 2017

1331

1 reference

BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition.

11 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824529

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824529

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824529

Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824529

The landscape of somatic copy-number alteration across human cancers

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824529

Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824529

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824529

From cancer genomes to oncogenic drivers, tumour dependencies and therapeutic targets

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824529

16 August 2018

Identifiers

DOI

10.18632/ONCOTARGET.1261

0 references

1 reference

11 November 2017

PubMed publication ID

23934756

1 reference